FABISPRAY

Phase III Trial for a Nasal Spray showed 99.9% Effectiveness Against C•19 + multiple countries have approved it. Ingredients are so safe, they’ve used to treat babies for decades. Yet, U.S. Health Officials continue to only promote a Bivalent mRNA only tested on mice.